Why two members of the FDA advisory panel on the Pfizer-BioNTech vaccine voted against approval

An FDA advisory panel voted Thursday to recommend emergency use authorization for Pfizer's vaccine, taking the U.S. one step closer to full approval. CNBC's Meg Tirrell reports.